Povinanz Gargle 1%
Natural health product licensed in Canada
- Licence holder
- Nanz Pharma
- NPN or DIN-HM
- 80147664
- Status
- Active licence
- Licence date
- 5 March 2026
- Revision date
- Not provided
- Form
- Gargarismes
- Route of administration
- Oromucosale
- Application type
- Générale (non traditionelle)
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Composé homopolymère de 1-éthényl-2-pyrrolidinone avec de l'iode Source : Povidone-iode | 1 % |
Non-medicinal ingredients
Néotame, Glycérine, Iodure de potassium, Eau purifiée, Propylène glycol, Alcool, Menthol, Phosphate de sodium dibasique anhydre
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescents et adultes | minimum: 9 years | minimum: 10 mL ; maximum: 15 mL | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Help treat viruses and bacteria that can lead to sore throats and oral infection. Helps treat mouth ulcers.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80147664
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.